Board of Directors
Life at Forty Seven
Immuno-oncologists eye up macrophage targets. Morrison, Nature Reviews Drug Discovery 2016 15, 373-374.
1 June 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
24 February 2016
CD47 blockade as another immune checkpoint therapy for cancer. Vonderheide, Nature Medicine 2015 21, 1122.
7 October 2015